Funding Round Overview

Update
Founded:
2000
Founders:
Roger Hajjar
Headquarters:
La Jolla, CA
Funding:
$132.50M
Categories:
Biotechnology

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Description

Update

Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. The company was founded in 2000 and is based in La Jolla, California.

Current Team (2)

Update

Board Members and Advisors (2)

Update

Funding Rounds (11) - $132.50M

Update

Investors (10)

Update

Offices/Locations (1)

Update
  • Office

    2223 Avenida de la Playa

    Suite 300

    La Jolla, CA 92037

    USA

Images (1)

Update
  • 698a312a49afc42905abc6ffe911c333